Sg Americas Securities, LLC Uni Qure N.V. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$4.39 - $5.43 $77,206 - $95,497	17,587 New	17,587 $79,000
Q4 2023 Jan 12, 2024	BUY	$5.63 - $8.27 $96,605 - $141,904	17,159 New	17,159 $116,000
Q1 2023 Apr 28, 2023	BUY	$18.7 - $23.07 $193,395 - $238,589	10,342 New	10,342 $208,000
Q3 2022 Oct 31, 2022	SELL	$16.98 - $25.54 $163,958 - $246,614	-9,656 Reduced 37.95%	15,791 $296,000
Q2 2022 Jul 29, 2022	SELL	$13.15 - $20.45 $9,441 - $14,683	-718 Reduced 2.74%	25,447 $474,000
Q1 2022 Apr 29, 2022	SELL	$14.54 - $21.5 $14,525 - $21,478	-999 Reduced 3.68%	26,165 $473,000
Q4 2021 Feb 07, 2022	SELL	$20.24 - $36.01 $53,312 - $94,850	-2,634 Reduced 8.84%	27,164 $563,000
Q3 2021 Nov 01, 2021	BUY	$26.01 - $38.22 $343,410 - $504,618	13,203 Added 79.56%	29,798 $954,000
Q2 2021 Aug 12, 2021	SELL	$29.97 - $37.17 $360,838 - $447,526	-12,040 Reduced 42.05%	16,595 $511,000
Q1 2021 May 13, 2021	BUY	$29.24 - $42.03 $473,190 - $680,171	16,183 Added 129.96%	28,635 $965,000
Q4 2020 Feb 04, 2021	SELL	$35.35 - $50.67 $149,636 - $214,486	-4,233 Reduced 25.37%	12,452 $450,000
Q3 2020 Nov 09, 2020	BUY	$35.98 - $47.66 $600,326 - $795,207	16,685 New	16,685 $615,000
Q2 2020 Jul 20, 2020	SELL	$45.06 - $67.74 $344,078 - $517,262	-7,636 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$40.01 - $73.97 $32,608 - $60,285	815 Added 11.95%	7,636 $362,000
Q4 2019 Jan 28, 2020	BUY	$37.13 - $74.62 $253,263 - $508,983	6,821 New	6,821 $489,000
Q3 2019 Nov 04, 2019	SELL	$39.36 - $76.8 $112,136 - $218,803	-2,849 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$52.76 - $82.19 $150,313 - $234,159	2,849 New	2,849 $223,000
Q1 2018 May 03, 2018	SELL	$17.1 - $26.61 $103,540 - $161,123	-6,055 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$9.47 - $19.59 $57,340 - $118,617	6,055	6,055 $119,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account